ConductScience.org, home

Paper32965124

Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways.

An L and 7 others. Nano Lett, 2020. Cited by 151 papers, by iCite.

Cite this record

ConductScience Library. Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways. Papers, record 32965124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32965124

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways.
PubMed
Journal
Nano Lett
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
151
iCite
Relative citation ratio, by iCite
8.06
iCite
Revised in PubMed
2021-06-24
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1An LLemei
2Li ZZhanrong
3Shi LLiuqi
4Wang LLiujun
5Wang YYong
6Jin LLinhttps://orcid.org/0000-0001-7969-5308
7Shuai XXintaohttps://orcid.org/0000-0003-4271-0310
8Li JJingguohttps://orcid.org/0000-0002-0471-4540

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, ExperimentalMajor topic
Arthritis, RheumatoidMajor topic
Animals
Inflammation
NF-kappa B
Pentacyclic Triterpenes

Cited by86

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 151 citations.

PMIDTitleJournalYearIn PapersSource
42953758Triptolide and Celastrol for Rheumatoid Arthritis: Mechanism-Guided Nanoarchitectonics for Delivery Strategies to Enhance Efficacy and Reduce Toxicity.Int J Nanomedicine2026https://conductscience.org/library/papers/42953758PubMed
42946860Deciphering the mechanistic landscape of notch signaling in autoimmune pathogenesis.Clin Exp Med2026https://conductscience.org/library/papers/42946860PubMed
42884078Celastrol in Rheumatoid Arthritis: Immunomodulatory Mechanisms, Multicellular Convergence, and Translational Challenges.Int J Mol Sci2026https://conductscience.org/library/papers/42884078PubMed
42763682Injectable Hyaluronic Acid-Functionalized Nanocomposite Hydrogel for Targeted Rheumatoid Arthritis Therapy via Concurrent ROS Attenuation and Macrophage Repolarization.Int J Nanomedicine2026https://conductscience.org/library/papers/42763682PubMed
42746078Folate-modified liposomal celastrol for rheumatoid arthritis: therapeutic efficacy and modulation of ROS/NF-κB/COX-2-related inflammatory signaling.Front Immunol2026https://conductscience.org/library/papers/42746078PubMed
42509726Overcoming the Druggability Hurdles of Celastrol: A Critical Review of Advanced Drug Delivery Strategies.Biomolecules2026https://conductscience.org/library/papers/42509726PubMed
42437940Macrophage Notch1 drives hepatocyte ferroptosis via the exosomal miR-142a-3p/TIPE2 axis to promote MASH progression.Cell Biosci2026https://conductscience.org/library/papers/42437940PubMed
42357311Orally Administered Self-Microemulsifying Celastrol Alleviates Rheumatoid Arthritis by Modulating the Expression of TNF-α.Pharmaceutics2026https://conductscience.org/library/papers/42357311PubMed
42325403Nanomedicine Strategies for Rheumatoid Arthritis: Precision Delivery and Immune Microenvironment Modulation.Int J Nanomedicine2026https://conductscience.org/library/papers/42325403PubMed
41910697Targeting NF-κB and JAK/STAT pathways in rheumatoid arthritis: emerging nanocarrier-based drug delivery approaches.Inflammopharmacology2026https://conductscience.org/library/papers/41910697PubMed
41883322Influence of heat-reinforcing Needling on the PPAR-γ/NF-κB signaling pathway in the synovial membrane of rats with rheumatoid arthritis.Histol Histopathol2026https://conductscience.org/library/papers/41883322PubMed
41767600Microfluidic Nanocomposite Lubricating Microgels Localized Deliver Celastrol for Remodeling the Immune Microenvironment to Enhance Osteoarthritis Treatment.Research (Wash D C)2026https://conductscience.org/library/papers/41767600PubMed
41737466Dynamic microenvironment-regulated hydrogels releasing celastrol lead to urethral scarless repair.Mater Today Bio2026https://conductscience.org/library/papers/41737466PubMed
41408107Celastrol suppresses bone destruction in rheumatoid arthritis by inhibiting ALOX5 expression in macrophages via the NF-κB pathway.Sci Rep2025https://conductscience.org/library/papers/41408107PubMed
41332942Prodrug-loaded micelles targeting articular cavity reactive oxygen species for rheumatoid arthritis treatment.Mater Today Bio2025https://conductscience.org/library/papers/41332942PubMed
40936516From Physicochemical Constraints to Clinical Prospects of Celastrol: Challenges and Nano Delivery Strategies.Int J Nanomedicine2025https://conductscience.org/library/papers/40936516PubMed
40874697Celastrol Activates SIRT1/PGC-1α/Nrf2 Axis to Inhibit Oxidative Damage for Subconjunctival Fibrosis Alleviation.Invest Ophthalmol Vis Sci2025https://conductscience.org/library/papers/40874697PubMed
40794372Therapeutic efficacy of celastrol in experimental polyarthritis: insights from a meta-analysis of in vivo studies.Inflammopharmacology2025https://conductscience.org/library/papers/40794372PubMed
40406100A comprehensive review of natural products in rheumatoid arthritis: therapeutic potential and mechanisms.Front Immunol2025https://conductscience.org/library/papers/40406100PubMed
40391077Celastrol suppresses neovascularization in rat aortic vascular endothelial cells stimulated by inflammatory tenocytes via modulating the NLRP3 pathway.Open Med (Wars)2025https://conductscience.org/library/papers/40391077PubMed

See all 86 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
NOTCH14851PubTator's text mininghttps://conductscience.org/library/genes/4851NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32965124

GET https://conductscience.org/api/papers/v1/32965124/cited_by?page=2